Brain cells found to transfer material to neurons in mice – Drug Target Review

About us | Advertise with us | Contact us


Posted: 21 April 2023 | Taylor Mixides (Drug Target Review) | No comments yet
Researchers have discovered that oligodendrocyte-lineage cells transfer cell material to neurons in a mouse brain. They have provided the first evidence of coordinated nuclear interaction between these cells and neurons.
In a study published in the Journal of Experimental Medicine researchers from University of California – Davis Health, US, have revealed how a particular type of brain cell, called oligodendrocyte-lineage cells, transfers cell material to neurons in the mouse brain. The researchers have provided the first evidence of coordinated nuclear interaction between these cells and neurons.
“This novel concept of material transfer to neurons opens new possibilities for understanding brain maturation and finding treatments for neurological conditions, such as Alzheimer’s disease, cerebral palsy, Parkinson’s, and Huntington’s disease,” said corresponding author Olga Chechneva. Assistant Project Scientist at the UC Davis Department of Biochemistry and Molecular Medicine.
Oligodendrocyte-lineage cells are a type of glial cell that can be found in the central nervous system. These cells are important for supporting the maturation of neural circuits from the time of birth. One of the main functions of oligodendrocyte-lineage cells is myelination, which involves creating a protective insulating layer called the myelin sheath around the nerve axons.
Satellite oligodendrocytes are a unique type of oligodendrocyte present in the grey matter of the central nervous system, near neuronal bodies. They play various roles, such as promoting the survival of neighbouring neurons, regulating the release of neurotransmitters, and adjusting synaptic activity.
“Research has mostly focused on studying the myelinating function of oligodendrocytes, while satellite oligodendrocytes and their interaction with neurons are not well understood,” Chechneva said.
The process of observing the interaction between glial cells and neurons began with an unplanned discovery. The scientists used unique fluorescent proteins to mark and follow the oligodendroglia in the brain and spinal cord of mice. To their surprise, they noticed that nuclear and ribosomal reporter proteins were not only found within these cells but also in the neurons of the mouse model.
Protein and molecule transfer is vital for neuronal survival and recovery post-injury. Material transfer occurs through tunnelling nanotubes, gap junctions, and extracellular vesicles. This study is the first to report material transfer to neurons by satellite oligodendrocytes in close contact with neurons, despite the interrupted plasma membrane.
“We are looking at the possibility of an additional new mechanism where the cell can directly transfer material to another cell, in particular a satellite oligodendrocyte to a neuron. We could clearly see that cell nuclei from both cells had come together, and the plasma membrane (the physical border between cells) was open,” Chechneva explained.
The study revealed that the transfer of materials between oligodendroglia and neurons starts to occur after birth, during a crucial time of brain development.
“The fact that this transfer process is established during postnatal development is very interesting. These are critical periods when the brain is maturing and brain circuits are formed,” Chechneva said.
“Our knowledge about this mechanism is extremely new, and it opens many questions for understanding how neurons work and its biological relevance in many neurological disorders. This is very exciting,” Chechneva added.
In addition to the above findings, the researchers observed that material transfer from oligodendroglia to neurons is heightened during chronic neuroinflammation. This discovery presents a potential avenue for developing more targeted therapies for neurodegenerative conditions that result from the accumulation of pathogenic proteins in neurons, including Alzheimer’s and Parkinson’s disease.
Related topics
Cell Therapy, Drug Delivery, Drug Discovery, Drug Discovery Processes, Drug Targets, In Vivo, Neurons, Neurosciences
Related conditions
Alzheimer’s, Parkinson’s
Related organisations
UC Davis Health, University of California (UC)
Related people
Olga Chechneva
By Taylor Mixides (Drug Target Review)
21 April 2023
No comments yet
Cell Therapy, Drug Delivery, Drug Discovery, Drug Discovery Processes, Drug Targets, In Vivo, Neurons, Neurosciences
Alzheimer’s, Parkinson’s
UC Davis Health, University of California (UC)
Olga Chechneva
All subscriptions include online membership, giving you access to the journal and exclusive content.
By Eurofins Discovery
By Bio-Techne
By Izzy Wood (Drug Target Review)
By Taylor Mixides (Drug Target Review)
By Drug Target Review
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website


Δ
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Write for us | Advertise with us
T: +44 (0)1959 563311
F: +44 (0)1959 563123

Drug Target Review is published by:
Russell Publishing Ltd.
Court Lodge
Hogtrough Hill
Brasted, Kent, TN16 1NU
United Kingdom
© Russell Publishing Limited, 2010-2023. All rights reserved. Terms & Conditions | Privacy Policy | Cookie Policy
Website development by e-Motive Media Limited.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as “Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies enable the core functionality of the website, including security, network management and accessibility. These cookies do not store any personal information. You may disable these by changing your browser settings, but this may affect how the website functions.

Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.

Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.

Performance cookies include cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.

source